BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34138495)

  • 1. Appraising prediction research: a guide and meta-review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST).
    de Jong Y; Ramspek CL; Zoccali C; Jager KJ; Dekker FW; van Diepen M
    Nephrology (Carlton); 2021 Dec; 26(12):939-947. PubMed ID: 34138495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale validation of the prediction model risk of bias assessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination.
    Venema E; Wessler BS; Paulus JK; Salah R; Raman G; Leung LY; Koethe BC; Nelson J; Park JG; van Klaveren D; Steyerberg EW; Kent DM
    J Clin Epidemiol; 2021 Oct; 138():32-39. PubMed ID: 34175377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies.
    Wolff RF; Moons KGM; Riley RD; Whiting PF; Westwood M; Collins GS; Reitsma JB; Kleijnen J; Mallett S;
    Ann Intern Med; 2019 Jan; 170(1):51-58. PubMed ID: 30596875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence.
    Collins GS; Dhiman P; Andaur Navarro CL; Ma J; Hooft L; Reitsma JB; Logullo P; Beam AL; Peng L; Van Calster B; van Smeden M; Riley RD; Moons KG
    BMJ Open; 2021 Jul; 11(7):e048008. PubMed ID: 34244270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Introduction of the Prediction model Risk Of Bias ASsessment Tool: a tool to assess risk of bias and applicability of prediction model studies].
    Chen R; Wang SF; Zhou JC; Sun F; Wei WW; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):776-781. PubMed ID: 32447924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-Rater Agreement in Assessing Risk of Bias in Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST): Results from a Controlled Experiment on the Effect of Specific Rater Training.
    Kaiser I; Pfahlberg AB; Mathes S; Uter W; Diehl K; Steeb T; Heppt MV; Gefeller O
    J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration.
    Moons KGM; Wolff RF; Riley RD; Whiting PF; Westwood M; Collins GS; Reitsma JB; Kleijnen J; Mallett S
    Ann Intern Med; 2019 Jan; 170(1):W1-W33. PubMed ID: 30596876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic metareview of prediction studies demonstrates stable trends in bias and low PROBAST inter-rater agreement.
    Langenhuijsen LFS; Janse RJ; Venema E; Kent DM; van Diepen M; Dekker FW; Steyerberg EW; de Jong Y
    J Clin Epidemiol; 2023 Jul; 159():159-173. PubMed ID: 37142166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common challenges and suggestions for risk of bias tool development: a systematic review of methodological studies.
    Tomlinson E; Cooper C; Davenport C; Rutjes AWS; Leeflang M; Mallett S; Whiting P
    J Clin Epidemiol; 2024 Apr; 171():111370. PubMed ID: 38670243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies.
    Kaiser I; Mathes S; Pfahlberg AB; Uter W; Berking C; Heppt MV; Steeb T; Diehl K; Gefeller O
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of bias in studies on prediction models developed using supervised machine learning techniques: systematic review.
    Andaur Navarro CL; Damen JAA; Takada T; Nijman SWJ; Dhiman P; Ma J; Collins GS; Bajpai R; Riley RD; Moons KGM; Hooft L
    BMJ; 2021 Oct; 375():n2281. PubMed ID: 34670780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for a systematic review on the methodological and reporting quality of prediction model studies using machine learning techniques.
    Andaur Navarro CL; Damen JAAG; Takada T; Nijman SWJ; Dhiman P; Ma J; Collins GS; Bajpai R; Riley RD; Moons KG; Hooft L
    BMJ Open; 2020 Nov; 10(11):e038832. PubMed ID: 33177137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining Bias and Reporting in Oral Health Prediction Modeling Studies.
    Du M; Haag D; Song Y; Lynch J; Mittinty M
    J Dent Res; 2020 Apr; 99(4):374-387. PubMed ID: 32028825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of prognostic models to predict stillbirth using International Prediction of Pregnancy Complications (IPPIC) Network database: individual participant data meta-analysis.
    Allotey J; Whittle R; Snell KIE; Smuk M; Townsend R; von Dadelszen P; Heazell AEP; Magee L; Smith GCS; Sandall J; Thilaganathan B; Zamora J; Riley RD; Khalil A; Thangaratinam S;
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):209-219. PubMed ID: 34405928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodological conduct of prognostic prediction models developed using machine learning in oncology: a systematic review.
    Dhiman P; Ma J; Andaur Navarro CL; Speich B; Bullock G; Damen JAA; Hooft L; Kirtley S; Riley RD; Van Calster B; Moons KGM; Collins GS
    BMC Med Res Methodol; 2022 Apr; 22(1):101. PubMed ID: 35395724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A literature review of quality assessment and applicability to HTA of risk prediction models of coronary heart disease in patients with diabetes.
    Jiu L; Wang J; Javier Somolinos-Simón F; Tapia-Galisteo J; García-Sáez G; Hernando M; Li X; Vreman RA; Mantel-Teeuwisse AK; Goettsch WG
    Diabetes Res Clin Pract; 2024 Mar; 209():111574. PubMed ID: 38346592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome prediction models incorporating clinical variables for Head and Neck Squamous cell Carcinoma: A systematic review of methodological conduct and risk of bias.
    Aly F; Hansen CR; Al Mouiee D; Sundaresan P; Haidar A; Vinod S; Holloway L
    Radiother Oncol; 2023 Jun; 183():109629. PubMed ID: 36934895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of prediction tools to identify adult hospitalized patients at risk of drug-related problems: A systematic review of clinical prediction models and risk assessment tools.
    Deawjaroen K; Sillabutra J; Poolsup N; Stewart D; Suksomboon N
    Br J Clin Pharmacol; 2022 Feb; 88(4):1613-1629. PubMed ID: 34626130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic models for predicting relapse or recurrence of major depressive disorder in adults.
    Moriarty AS; Meader N; Snell KI; Riley RD; Paton LW; Chew-Graham CA; Gilbody S; Churchill R; Phillips RS; Ali S; McMillan D
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013491. PubMed ID: 33956992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.